InProTher Announces EUR 6M Seed Financing with the Participation of the European Innovation Council Fund to Develop First-In-Class Cancer Immunotherapy
Danish start-up developing immunotherapies designed to fight the tumors from within Financing supports GMP and toxicology studies and will advance InProTher’s first-in-class cancer immunotherapy into First-in-Human clinical trials Strengthens team with appointment of industry heavyweights Dr. Sven Rohmann as Chairman and Dr. Hamina Patel as CMO COPENHAGEN, Denmark, May 24, 2023 /PRNewswire/ — InProTher, an … Read more